Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 57
  • 0 comments

FDA approve APIXABAN

Comment Full text

HIKMA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 45
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text

BAUSCH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 50
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

SUNSHINE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 48
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 61
  • 0 comments

FDA approve RANOLAZINE

Comment Full text

STIRA

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 61
  • 0 comments

FDA approve ZINC CHLORIDE

Comment Full text

RECORDATI RARE

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 60
  • 0 comments

FDA approve OSILODROSTAT PHOSPHATE

Comment Full text

ALCON LABS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 63
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 58
  • 0 comments

FDA approve CARBIDOPA; ENTACAPONE; LEVODOPA

Comment Full text

MSN

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 50
  • 0 comments

FDA approve RUFINAMIDE

Comment Full text
  • Previous
  • 198
  • 199
  • 200
  • 201
  • 202
  • Next

Search

News categories

  • Technical Exchange News(11369)
  • Event(2790)
  • SEC News(205819)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(134632)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin